Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Market Outlook 2026-2034: Market Share, and Growth Analysis" report has been added to ResearchAndMarkets.com's offering.The Semaglutide...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Semaglutide Preparations Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.As the competitive As the...

Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, Tirzepatide), Type (Patented, Biosimilars), Format (Single Dose,...

U.S. JPML has created a new multidistrict litigation for lawsuits alleging that GLP-1 receptor agonist drugs cause NAION, a serious vision injury.

NorthStrive Biosciences Advances to Phase III of AI-Driven Drug Discovery Program Toward Validation of Multiple Potential Drug Compounds & Discoveries

SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present...

Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Semaglutide Market Report by Product, Application, Distribution Channel, States and Company Analysis, 2025-2033" has been added to ...

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...

PORTLAND, Ore., Sept. 23, 2025 (GLOBE NEWSWIRE) -- When it comes to GLP-1 weight loss medications, including Ozempic®, Zepbound® and Wegovy®, having access is only part of the equation. Patients need...

Denver, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Actual Veggies, a CPG leader known for its chef-crafted veggie burgers and vegetable-forward products, has been named to the 2025 Inc. 5000 list of...